WINT Forecast. What You Should Know.
WINT Historical Ratings and Targets
About Windtree Therapeutics Inc
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.